Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

BCLI Stock Annual Income Statement. Download in Excel

Brainstorm Cell Therapeutics Inc. logo

Brainstorm Cell Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

1.46
 
USD
  
-0.17
  
(-10.43%)
Previous close: 1.63  Open: 1.57  Bid: 1.5  Ask: 1.53
52 week range    
1.05   
   11.89
Mkt Cap: 10 M  Avg Vol (90 Days): 89,577
Peers   
GILD / 
CYTK / 
BIIB / 
BIEI / 
AGEN / 
SGEN / 
Last updated: Friday 6th December 2024

Stock Rankings

15
Technical
21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

BCLI Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-1.07-0.68-0.66-0.4
Basic EPS total-1.07-0.68-0.66-0.4
Basic weighted shares outstanding14 M18 M19 M19 M20 M22 M30 M36 M37 M43 M
Depreciation-106000.0-87000.0-77000.0-85000.0-110000.0-164000.0219000.0260000.0285000.0265000.0
DepreciationAndAmortization-106000.0-87000.0-77000.0-85000.0-110000.0-164000.0219000.0260000.0285000.0265000.0
Diluted EPS total-0.7-1.06-1.07-0.68-0.66-0.4
Diluted normalized net income/share-0.68-0.66-0.4
Diluted weighted shares outstanding20 M22 M30 M36 M37 M43 M
GeneralAndAdministrativeExpense3 M4 M3 M4 M6 M6 M9 M9 M11 M11 M
Income before tax-7 M-9 M-5 M-5 M-14 M-23 M-32 M-25 M-25 M-21 M
Income restructuring and M&A910000.0
MiscOtherSpecialCharges5 M
Net income from total operations-9 M-8 M-5 M-5 M-14 M-23 M-32 M-24 M-24 M-17 M
NetIncomeCommonStockholders-9 M-8 M-5 M-5 M-14 M-23 M-32 M-24 M-24 M-17 M
NetIncomeContinuousOperations-9 M-8 M-5 M-5 M-14 M-23 M-32 M-24 M-25 M-21 M
NetIncomeFromOtherGainsLosses-2 M48000.0101000.047000.0115000.0-252000.0127000.082000.0545000.04 M
Operating income-7 M-9 M-5 M-5 M-14 M-23 M-32 M-25 M-25 M-21 M
Operating income before depreciation (EBITDA)-7 M-8 M-5 M-5 M-14 M-23 M-31 M-24 M-25 M-21 M
OperatingExpense7 M9 M5 M5 M14 M23 M32 M25 M25 M21 M
Other income net-5 M
OtherGandA3 M4 M3 M4 M6 M6 M9 M9 M11 M11 M
OtherOperatingExpenses-164000.0-161000.0-134000.01 M3 M975000.01 M
RentAndLandingFees3 M4 M3 M4 M6 M6 M
Research & development expense5 M5 M2 M977000.08 M17 M22 M15 M14 M11 M
ResearchExpense5 M5 M2 M977000.08 M17 M22 M15 M14 M11 M
RestructringAndMnAIncome910000.0
SalariesAndWages-1 M-943000.0-756000.0-616000.0-1 M-789000.03 M1 M2 M1 M
Selling Gen & administrative expense3 M4 M3 M4 M6 M6 M9 M9 M11 M11 M
Special income/charges-910000.0
Total Income available for interest expense (EBIT)-7 M-9 M-5 M-5 M-14 M-23 M-32 M-25 M-25 M-21 M
Total common shares outstanding18 M19 M19 M19 M29 M26 M36 M36 M37 M68 M
Total net income-9 M-8 M-5 M-5 M-14 M-23 M-32 M-24 M-24 M-17 M
Total ordinary shares80 M80 M80 M80 M80 M80 M80 M80 M80 M80 M
TotalExpenses7 M9 M5 M5 M14 M23 M32 M25 M25 M21 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University